Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Neos Therapeutics Inc. NEOS

Healthcare Drug Manufacturers - Major
Neos Therapeutics Inc is a pharmaceutical company, engaged in the development, manufacture, and commercialization of products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technologies. The product portfolio of the company includes Methylphenidate XR-ODT and Amphetamine XR oral suspension commonly prescribed medicine for the treatment of ADHD. In... see more

Recent & Breaking News (NDAQ:NEOS)

Neos Therapeutics Reports Third Quarter 2020 Financial Results

GlobeNewswire November 9, 2020

Neos Therapeutics to Host Third Quarter 2020 Financial and Operating Results Conference Call on November 9th, 2020

GlobeNewswire November 2, 2020

Neos Therapeutics to Present at Cantor Virtual Global Healthcare Conference

GlobeNewswire September 9, 2020

Neos Therapeutics Reports Second Quarter 2020 Financial Results

GlobeNewswire August 10, 2020

Neos Therapeutics to Host Second Quarter 2020 Financial and Operating Results Conference Call on August 10th, 2020

GlobeNewswire August 3, 2020

Neos Therapeutics to Present at BMO 2020 Prescriptions for Success Healthcare Conference

GlobeNewswire June 16, 2020

Neos Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference

GlobeNewswire May 26, 2020

Neos Therapeutics Reports First Quarter 2020 Financial Results

GlobeNewswire May 11, 2020

Neos Therapeutics to Host First Quarter 2020 Financial and Operating Results Conference Call on May 11th, 2020

GlobeNewswire May 4, 2020

Neos Therapeutics Announces Issuance of New U.S. Methods of Use Patent for N-desethyloxybutynin

GlobeNewswire April 9, 2020

Neos Therapeutics Statement: COVID-19 Update

GlobeNewswire March 30, 2020

Neos Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results

GlobeNewswire March 13, 2020

Neos Therapeutics to Host Fourth Quarter and Year-End 2019 Financial and Operating Results Conference Call on March 13th, 2020

GlobeNewswire March 6, 2020

Neos Therapeutics to Present at the Cowen & Co. 40th Annual Health Care Conference

GlobeNewswire February 26, 2020

Neos Therapeutics Initiates and Completes Dosing in a Phase 1 Trial of NT0502 for the Treatment of Chronic Sialorrhea

GlobeNewswire January 13, 2020

Neos Therapeutics Reports Third Quarter 2019 Financial Results

GlobeNewswire November 8, 2019

Neos Therapeutics to Host Third Quarter 2019 Financial and Operating Results Conference Call on November 8, 2019

GlobeNewswire November 1, 2019

Neos Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference

GlobeNewswire September 25, 2019

Neos Therapeutics to Present at Two Upcoming September Conferences

GlobeNewswire August 29, 2019

Neos Therapeutics Reports Second Quarter 2019 Financial Results

GlobeNewswire August 8, 2019